Female founders
International expansion
St Pierre Groupe
Succession planning
The medtech company TidalSense, formerly Cambridge Respiratory Innovations (CRI), creates ground-breaking respiratory technologies for quicker, more accurate, and automated diagnostics.
TidalSense first received funding from BGF and Downing Ventures in December 2020, to fast-track research and development of its award-winning N-Tidal device.
The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing. It helps medical professionals diagnose and monitor respiratory conditions.
We’ve already helped hundreds of ambitious businesses in the UK and Ireland to accelerate their growth. If you’re looking for a minority investment partner that can provide long-term, flexible funding and support, please get in touch with our team today.
